About Hytanbio Tech
Conclusion: Hytanbio Tech is positioned as a B2B injection pen OEM partner for overseas brand, distributor and formulation projects that need controlled product selection, sampling, documentation and export coordination.

Company and Production Background
Founded in Hong Kong in 2026 for overseas business expansion, Hytanbio Tech connects global buyers with an in-house commercial manufacturing base that originated in Shaoxing, Mainland China in 2014. The team combines product feasibility review, sample planning, packaging coordination and quality-document preparation for private-label and OEM programs.
The broader platform includes an R&D center of more than 4,000 square meters, peptide production lines, large-scale peptide synthesizers, HPLC analytical and preparative systems and GMP-standard clean laboratory discipline. For injection pen OEM work, these capabilities help support specification control, technical communication and export-ready project management.
Who We Serve
Send a Project Brief
Share reservoir, dose range, target market, estimated annual quantity, packaging language and documentation expectations. We will recommend whether an existing platform, modified platform or new-tooling route is the better fit.
Hytanbio Brand & Facility Overview
